341 related articles for article (PubMed ID: 17372216)
1. An acquired hypocalciuric hypercalcemia autoantibody induces allosteric transition among active human Ca-sensing receptor conformations.
Makita N; Sato J; Manaka K; Shoji Y; Oishi A; Hashimoto M; Fujita T; Iiri T
Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5443-8. PubMed ID: 17372216
[TBL] [Abstract][Full Text] [Related]
2. Cinacalcet corrects biased allosteric modulation of CaSR by AHH autoantibody.
Makita N; Ando T; Sato J; Manaka K; Mitani K; Kikuchi Y; Niwa T; Ootaki M; Takeba Y; Matsumoto N; Kawakami A; Ogawa T; Nangaku M; Iiri T
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996138
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hypocalciuric hypercalcemia unresponsive to glucocorticoid therapy in a patient with blocking autoantibodies against the calcium-sensing receptor.
Pallais JC; Kemp EH; Bergwitz C; Kantham L; Slovik DM; Weetman AP; Brown EM
J Clin Endocrinol Metab; 2011 Mar; 96(3):672-80. PubMed ID: 21159843
[TBL] [Abstract][Full Text] [Related]
4. Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies.
Makita N; Sato J; Manaka K; Akahane K; Ito T; Yamazaki H; Mizoguchi A; Hikima Y; Horikoshi H; Nangaku M; Iiri T
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36099030
[TBL] [Abstract][Full Text] [Related]
5. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
7. Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor.
Davey AE; Leach K; Valant C; Conigrave AD; Sexton PM; Christopoulos A
Endocrinology; 2012 Mar; 153(3):1232-41. PubMed ID: 22210744
[TBL] [Abstract][Full Text] [Related]
8. Biased agonism: a novel paradigm in G protein-coupled receptor signaling observed in acquired hypocalciuric hypercalcemia.
Makita N; Iiri T
Endocr J; 2014; 61(4):303-9. PubMed ID: 24240576
[TBL] [Abstract][Full Text] [Related]
9. Acquired hypocalciuric hypercalcemia in a patient with CKD.
Kuo E; Kemp EH; Sandhu HK; Brown EM; Weetman AP; Huang CL
Am J Kidney Dis; 2013 Dec; 62(6):1151-4. PubMed ID: 23810542
[TBL] [Abstract][Full Text] [Related]
10. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Hypercalcemia Due to Autoantibodies Against the Calcium-sensing Receptor.
Miñambres I; Corcoy R; Weetman AP; Kemp EH
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32311038
[TBL] [Abstract][Full Text] [Related]
12. [Calcimimetics--a new treatment for hyperparathyroidism?].
Piecha G; Chudek J; Wiecek A
Pol Merkur Lekarski; 2005 May; 18(107):581-4. PubMed ID: 16161961
[TBL] [Abstract][Full Text] [Related]
13. Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Babinsky VN; Hannan FM; Gorvin CM; Howles SA; Nesbit MA; Rust N; Hanyaloglu AC; Hu J; Spiegel AM; Thakker RV
J Biol Chem; 2016 May; 291(20):10876-85. PubMed ID: 26994139
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-responsive lymphocytic parathyroiditis and hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor: a case report and literature review.
Song L; Liu L; Miller RT; Yan SX; Jackson N; Holt SA; Maalouf NM
Eur J Endocrinol; 2017 Jul; 177(1):K1-K6. PubMed ID: 28515208
[TBL] [Abstract][Full Text] [Related]
15. Calcium-Sensing Receptor Internalization Is
Mos I; Jacobsen SE; Foster SR; Bräuner-Osborne H
Mol Pharmacol; 2019 Oct; 96(4):463-474. PubMed ID: 31399503
[TBL] [Abstract][Full Text] [Related]
16. Effect of the calcimimetic R-568 [3-(2-chlorophenyl)-N-((1R)-1-(3-methoxyphenyl)ethyl)-1-propanamine] on correcting inactivating mutations in the human calcium-sensing receptor.
Lu JY; Yang Y; Gnacadja G; Christopoulos A; Reagan JD
J Pharmacol Exp Ther; 2009 Dec; 331(3):775-86. PubMed ID: 19759318
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in
Hao Y; Lei Z; Shi N; Yu L; Ji W; Zhang X
Front Endocrinol (Lausanne); 2021; 12():743517. PubMed ID: 35095753
[TBL] [Abstract][Full Text] [Related]
18. Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cells.
Avlani VA; Ma W; Mun HC; Leach K; Delbridge L; Christopoulos A; Conigrave AD
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1097-104. PubMed ID: 23531616
[TBL] [Abstract][Full Text] [Related]
19. Control of renal calcium, phosphate, electrolyte, and water excretion by the calcium-sensing receptor.
Tyler Miller R
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):345-58. PubMed ID: 23856264
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
